AAO 2024 Highlights: Aging Clinicians, Presbyopia Drop, Modern Anesthesia, and AMD Advancements
• Alfredo Sadun, MD, addressed the challenges of aging clinicians in ophthalmology, highlighting the complexities of assessing competency and avoiding ageism.
• Jennifer Loh, MD, presented data on CSF-1, a low-dose pilocarpine drop, demonstrating a 30% mean reduction in pupil size and improved near visual acuity without affecting distance vision.
• Brent Kramer, MD, discussed the benefits of the MKO Melt for cataract surgery, emphasizing improved patient and team experience due to its opioid-free, needle-free approach.
• Researchers at Wilmer Eye Institute found that increased ANGPTL4 may counteract anti-VEGF therapy in wet AMD and that experimental drug 32-134D could enhance treatment efficacy.
Travoprost Clinical Trials Show Promise, Uveitis Incidence Data Presented, and Gel Anesthesia for Injections
• Dr. John Berdahl of Vance Thompson Vision discussed the promising clinical trial results of travoprost, offering new insights into its efficacy.
• Meghan Berkenstock presented data on the incidence and prevalence of uveitis and associated ocular complications using the US TriNetX Database.
• Dr. Michael Singer shared research findings on the effectiveness of gel versus traditional drops for anesthesia during intravitreal injections, highlighting potential benefits.
© Copyright 2025. All Rights Reserved by MedPath